Satellos
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
200 Bay St Suite 2800, Toronto, Ontario,...Phone Number
(647) 660-1780Website
www.satellos.comRevenue
-Stock Symbol
MSCLFIndustry
About Satellos
Satellos is dedicated to improving the treatment of Duchenne muscular dystrophy and other muscle diseases through the development of small molecule therapeutics. Their lead drug candidate, forazapadin, aims to enhance muscle regeneration by guiding muscle stem cells to divide asymmetrically, thereby repairing and regenerating damaged tissue. The company is also expanding its research to include other conditions characterized by muscle mass loss, such as facioscapulohumeral muscular dystrophy (FSHD). Satellos targets patients suffering from these debilitating muscle diseases, striving to restore their natural ability to regenerate muscle.Explore more
SIC Code 28,283NAICS Code 32,325Ticker OTC: MSCLFShow moreSatellos Org Chart
Compare Similar Companies to Satellos
Compare insights from companies similar to Satellos, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Satellos Tech Stack
A closer look at the technologies used by Satellos
Top Manufacturing Companies
Frequently Asked Questions Regarding Satellos
Sign Up For FreeTo access detailed company insights
Satellos is dedicated to improving the treatment of Duchenne muscular dystrophy and other muscle diseases through the development of small molecule therapeutics. Their lead drug candidate, forazapadin, aims to enhance muscle regeneration by guiding muscle stem cells to divide asymmetrically, thereby repairing and regenerating damaged tissue. The co... Read More

